Search

Your search keyword '"Guzman, Jaime"' showing total 682 results
Start Over Author "Guzman, Jaime"
682 results on '"Guzman, Jaime"'

3. Relationship of Fatigue, Pain Interference, and Physical Disability in Children Newly Diagnosed With Juvenile Idiopathic Arthritis

Author

Choong, Naomi, Batthish, Michelle, Berard, Roberta A., Chédeville, Gaëlle, Feldman, Brian M., Houghton, Kristin M., Huber, Adam M., James, Sarah, Proulx‐Gauthier, Jean‐Philippe, Rumsey, Dax G., Schmeling, Heinrike, Toupin‐April, Karine, Guzman, Jaime, Cabral, David A., Chédeville, Gaëlle, Duffy, Ciarán M., Gerhold, Kerstin, Guzman, Jaime, Hiraki, Linda, Huber, Adam M., Schmeling, Heinrike, Shiff, Natalie J., Tucker, Lori B., Barsalou, Julie, Basodan, Daniah, Batthish, Michelle, Berard, Roberta A., Blanchette, Nicholas, Boire, Gilles, Bolaria, Roxana, Bruns, Alessandra, Cabral, David, Campillo, Sarah, Cellucci, Tania, Chan, Mercedes, Chédeville, Gaëlle, Chhabra, Amieleena, Couture, Julie, Dancey, Paul, De Bruycker, Jean‐Jacques, Demirkaya, Erkan, Dhalla, Muhammed, Duffy, Ciarán M., El Tal, Talal, Gerschman, Tommy, Guzman, Jaime, Heale, Liane, Herrington, Julie, Houghton, Kristin M., Huber, Adan M., Human, Andrea, Johnson, Nicole, Jurencak, Roman, Lang, Bianca, LeBlanc, Claire, Lim, Lilian, Lim, Lily S. H., Luca, Nadia, McColl, Jeanine, McGrath, Tara, McMillan, Tamara, McPherson, Megan, Miettunen, Paivi, Morishita, Kimberly, Ng, Honyan, Park, Jonathan, Proulx‐Gauthier, Jean‐Philippe, Roth, Johannes, Rozenblyum, Evelyn, Rumsey, Dax G., Schmeling, Heinrike, Scuccimarri, Rosie, Soon, Gordon, Stevenson, Rebeka, Stringer, Elizabeth, Tam, Herman, Tucker, Lori B., Twilt, Marinka, Verstegen, Ruud H. J., and Duffy, Karen Watanabe

Abstract

Our objectives were to quantify the relationships among fatigue, pain interference, and physical disability in children with juvenile idiopathic arthritis (JIA) and to test whether fatigue mediates the relationship between pain interference and physical disability in JIA. Patients enrolled within three months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry between February 2017 and May 2023 were included. Their parents completed the Patient‐Reported Outcomes Measurement Information System fatigue and pain interference short proxy questionnaires and the Childhood Health Assessment Questionnaire disability index at registry enrollment. Associations were assessed using Pearson correlations and multiple linear regression. Structural equation modeling (SEM) was used to test if fatigue mediates the relationship between pain interference and physical disability. Among 855 patients (61.4% female, 44.1% with oligoarthritis), most reported fatigue and pain interference scores similar to those in the reference population, but 15.6% reported severe fatigue and 7.3% reported severe pain interference, with wide variation across JIA categories. Fatigue was strongly correlated with pain interference (r = 0.72, P< 0.001) and with physical disability (r= 0.60, P< 0.001). Pain interference (β = 0.027, P< 0.001) and fatigue (β = 0.013, P< 0.001) were both associated with physical disability after controlling for each other and potential confounders. SEM supported our hypothesis that fatigue partially mediates the relationship between pain interference and physical disability. Our findings suggest both fatigue and pain interference are independently associated with physical disability in children newly diagnosed with JIA, and the effect of pain interference may be partly mediated by fatigue.

Published
2024
Full Text
View/download PDF

4. Hereditary cerebral small vessel disease: Assessment of a HTRA1 variant using protein stability predictors and 3D modelling

Author

Hidalgo Mayoral, Irene, Martínez-Salio, Antonio, Llamas-Velasco, Sara, Gómez-Majón, Irene, Arteche-López, Ana, Quesada-Espinosa, Juan Francisco, Palma Milla, Carmen, Lezana Rosales, Jose Miguel, Pérez de la Fuente, Rubén, Juárez Rufián, Alexandra, Sierra Tomillo, Olalla, Sánchez Calvín, Maria Teresa, Gómez Rodríguez, Maria José, Ramos Gómez, Patricia, Villarejo-Galende, Alberto, Díaz-Guzmán, Jaime, Ortega-Casarrubios, Maria Ángeles, Calleja-Castaño, Patricia, and Moreno-García, Marta

Published
2022
Full Text
View/download PDF

7. Disruption of mitochondrial complex I induces progressive parkinsonism

Author

González-Rodríguez, Patricia, Zampese, Enrico, Stout, Kristen A., Guzman, Jaime N., Ilijic, Ema, Yang, Ben, Tkatch, Tatiana, Stavarache, Mihaela A., Wokosin, David L., Gao, Lin, Kaplitt, Michael G., Lopez-Barneo, Jose, Schumacher, Paul T., and Surmeier, D. James

Subjects
Parkinsonism -- Development and progression, Mitochondria -- Physiological aspects, Environmental issues, Science and technology, Zoology and wildlife conservation
Abstract

Loss of functional mitochondrial complex I (MCI) in the dopaminergic neurons of the substantia nigra is a hallmark of Parkinson's disease.sup.1. Yet, whether this change contributes to Parkinson's disease pathogenesis is unclear.sup.2. Here we used intersectional genetics to disrupt the function of MCI in mouse dopaminergic neurons. Disruption of MCI induced a Warburg-like shift in metabolism that enabled neuronal survival, but triggered a progressive loss of the dopaminergic phenotype that was first evident in nigrostriatal axons. This axonal deficit was accompanied by motor learning and fine motor deficits, but not by clear levodopa-responsive parkinsonism--which emerged only after the later loss of dopamine release in the substantia nigra. Thus, MCI dysfunction alone is sufficient to cause progressive, human-like parkinsonism in which the loss of nigral dopamine release makes a critical contribution to motor dysfunction, contrary to the current Parkinson's disease paradigm.sup.3,4. Dysfunction of mitochondrial complex I in mice is sufficient to cause progressive parkinsonism in which the loss of nigral dopamine release critically contributes to motor dysfunction., Author(s): Patricia González-Rodríguez [sup.1] , Enrico Zampese [sup.1] , Kristen A. Stout [sup.1] , Jaime N. Guzman [sup.1] , Ema Ilijic [sup.1] , Ben Yang [sup.1] , Tatiana Tkatch [sup.1] [...]

Published
2021
Full Text
View/download PDF

9. Parent‐Reported Medication Side Effects and Their Impact on Health‐Related Quality of Life in Children With Juvenile Idiopathic Arthritis

Author

Chédeville, Gaëlle, McGuire, Katherine, Cabral, David A., Shiff, Natalie J., Rumsey, Dax G., Proulx‐Gauthier, Jean‐Philippe, Schmeling, Heinrike, Berard, Roberta A., Batthish, Michelle, Soon, Gordon, Gerhold, Kerstin, Gerschman, Tommy, Bruns, Alessandra, Duffy, Ciaran M., Tucker, Lori B., and Guzman, Jaime

Published
2022
Full Text
View/download PDF

14. An Analysis of a Methodology that Transforms the Entity-Relationship Model into a Conceptual Model for a Graph Database

Author

Villa, Fernán, Moreno, Francisco, Guzmán, Jaime, Akan, Ozgur, Series Editor, Bellavista, Paolo, Series Editor, Cao, Jiannong, Series Editor, Coulson, Geoffrey, Series Editor, Dressler, Falko, Series Editor, Ferrari, Domenico, Series Editor, Gerla, Mario, Series Editor, Kobayashi, Hisashi, Series Editor, Palazzo, Sergio, Series Editor, Sahni, Sartaj, Series Editor, Shen, Xuemin (Sherman), Series Editor, Stan, Mircea, Series Editor, Xiaohua, Jia, Series Editor, Zomaya, Albert Y., Series Editor, Miraz, Mahdi H., editor, Excell, Peter, editor, Ware, Andrew, editor, Soomro, Safeeullah, editor, and Ali, Maaruf, editor

Published
2018
Full Text
View/download PDF

16. Spanish multidisciplinary clinical practice guidelines for Anderson–Fabry disease in adults. I. Method and recommendations

Author

Calderón Sandubete, E.J., Briones Pérez de la Blanca, E., Alonso-Ortiz del Río, C., Santamaría Olmo, R., López Mendoza, M., Barcos Martínez, M., Márquez Infante, C., Marín-León, I., Posada de la Paz, Manuel, Castellano, Pilar Giraldo, Blanes, Juan Ramón Gimeno, Navarro, Encarnación Guillén, Rodríguez, Mónica López, Arduán, Alberto Ortiz, Guzmán, Jaime Díaz, Martínez, Paz Latre, Villalba, Jordi Cruz, and Pérez, José María Carrión

Published
2019
Full Text
View/download PDF

18. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry

Author

Nguyen, Kelly, primary, Barsalou, Julie, additional, Basodan, Daniah, additional, Batthish, Michelle, additional, Benseler, Susanne M, additional, Berard, Roberta A, additional, Blanchette, Nicholas, additional, Boire, Gilles, additional, Bolaria, Roxana, additional, Bruns, Alessandra, additional, Cabral, David A, additional, Cameron, Bonnie, additional, Campillo, Sarah, additional, Cellucci, Tania, additional, Chan, Mercedes, additional, Chédeville, Gaëlle, additional, Chetaille, Anne-Laure, additional, Chhabra, Amieleena, additional, Couture, Julie, additional, Dancey, Paul, additional, De Bruycker, Jean-Jacques, additional, Demirkaya, Erkan, additional, Dhalla, Muhammed, additional, Duffy, Ciarán M, additional, Feldman, Brian M, additional, Feldman, Debbie E, additional, Gerschman, Tommy, additional, Haddad, Elie, additional, Heale, Liane, additional, Herrington, Julie, additional, Houghton, Kristin, additional, Huber, Adam M, additional, Human, Andrea, additional, Johnson, Nicole, additional, Jurencak, Roman, additional, Lang, Bianca, additional, Larché, Maggie, additional, Laxer, Ronald M, additional, LeBlanc, Claire M, additional, Lee, Jennifer J Y, additional, Levy, Deborah M, additional, Lim, Lillian, additional, Lim, Lily S H, additional, Luca, Nadia, additional, McGrath, Tara, additional, McMillan, Tamara, additional, Miettunen, Paivi M, additional, Morishita, Kimberly A, additional, Ng, Hon Yan, additional, Oen, Kiem, additional, Park, Jonathan, additional, Petty, Ross E, additional, Proulx-Gauthier, Jean-Philippe, additional, Ramsey, Suzanne, additional, Roth, Johannes, additional, Rosenberg, Alan M, additional, Rozenblyum, Evelyn, additional, Rumsey, Dax G, additional, Schmeling, Heinrike, additional, Schneider, Rayfel, additional, Scuccimarri, Rosie, additional, Shiff, Natalie J, additional, Silverman, Earl, additional, Soon, Gordon, additional, Spiegel, Lynn, additional, Stringer, Elizabeth, additional, Tam, Herman, additional, Tse, Shirley M, additional, Tucker, Lori B, additional, Turvey, Stuart, additional, Twilt, Marinka, additional, Duffy, Karen Watanabe, additional, Yeung, Rae S M, additional, and Guzman, Jaime, additional

Published
2023
Full Text
View/download PDF

24. A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care

Author

Barber, Claire E. H., Twilt, Marinka, Pham, Tram, Currie, Gillian R., Benseler, Susanne, Yeung, Rae S. M., Batthish, Michelle, Blanchette, Nicholas, Guzman, Jaime, Lang, Bianca, LeBlanc, Claire, Levy, Deborah M., O’Brien, Christine, Schmeling, Heinrike, Soon, Gordon, Spiegel, Lynn, Whitney, Kristi, and Marshall, Deborah A.

Published
2020
Full Text
View/download PDF

25. Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress

Author

Guzman, Jaime N., Ilijic, Ema, Yang, Ben, Sanchez-Padilla, Javier, Wokosin, David, Galtieri, Dan, Kondapalli, Jyothisri, Schumacker, Paul T., and Surmeier, D. James

Subjects
Oxidative stress -- Drug therapy -- Research, Isradipine -- Dosage and administration, Health care industry
Abstract

The ability of the Cav1 channel inhibitor isradipine to slow the loss of substantia nigra pars compacta (SNc) dopaminergic (DA) neurons and the progression of Parkinson's disease (PD) is being tested in a phase 3 human clinical trial. But it is unclear whether and how chronic isradipine treatment will benefit SNc DA neurons in vivo. To pursue this question, isradipine was given systemically to mice at doses that achieved low nanomolar concentrations in plasma, near those achieved in patients. This treatment diminished cytosolic [Ca.sup.2+] oscillations in SNc DA neurons without altering autonomous spiking or expression of [Ca.sup.2+] channels, an effect mimicked by selectively knocking down expression of Cav1.3 channel subunits. Treatment also lowered mitochondrial oxidant stress, reduced a high basal rate of mitophagy, and normalized mitochondrial mass--demonstrating that Cav1 channels drive mitochondrial oxidant stress and turnover in vivo. Thus, chronic isradipine treatment remodeled SNc DA neurons in a way that should not only diminish their vulnerability to mitochondrial challenges, but to autophagic stress as well., Introduction The loss of substantia nigra pars compacta (SNc) dopaminergic (DA) neurons is a defining feature of Parkinson's disease (PD) and is responsible for the core motor symptoms of the [...]

Published
2018
Full Text
View/download PDF

29. Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry

Author

Semalulu, Teresa, Berard, Roberta, Beattie, Karen, Basodan, Daniah, Boire, Gilles, Bolaria, Roxana, Cabral, David, Chhabra, Amieleena, Gerschman, Tommy, Johnson, Nicole, Herrington, Julie, Houghton, Kristin, Lim, Lillian, Miettunen, Paivi Maria Hannele, Park, Jonathan, Proulx-Gauthier, Jean-Philippe, Schmeling, Heinrike, Scuccimarri, Rosie, Tam, Herman, Tucker, Lori, Guzman, Jaime, and Batthish, Michelle

Abstract

ObjectiveUsing Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) juvenile idiopathic arthritis (JIA) registry data, we describe (1) clinical characteristics of patients with JIA transitioning to adult care, (2) prevalence of disease-related damage and complications, and (3) changes in disease activity during the final year prior to transfer.MethodsRegistry participants who turned 17 years between February 2017 and November 2021 were included. Clinical characteristics and patient-reported outcomes (PROs) at the last recorded pediatric rheumatology visit, and changes observed in the year prior to that visit were analyzed. Physicians completed an additional questionnaire characterizing cumulative disease-related damage and adverse events by age 17 years.ResultsAt their last visit, 88 of 131 participants (67%) had inactive and 42 (32%) had active disease. Overall, 96 (73%) were on medications and 41 (31%) were on biologic disease-modifying antirheumatic drugs. Among 80 participants for whom the additional questionnaire was completed, 26% had clinically detected joint damage, 31% had joint damage on imaging, 14% had uveitis, and 7.5% had experienced at least 1 serious adverse event. During the final year, 44.2% of patients were in remission, 28.4% attained inactive disease, and 27.4% became or remained active. Mean scores of PROs were stable overall during that last year, but a minority reported marked worsening.ConclusionA substantial proportion of youth with JIA transitioning to adult care in Canada had a high disease burden, which was reflected by their degree of disease activity, joint damage, or ongoing medication use. These results will inform pediatric and adult providers of anticipated needs during transition of care.

Published
2024
Full Text
View/download PDF

35. Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons

Author

Zampese, Enrico, primary, Wokosin, David L., additional, Gonzalez-Rodriguez, Patricia, additional, Guzman, Jaime N., additional, Tkatch, Tatiana, additional, Kondapalli, Jyothisri, additional, Surmeier, William C., additional, D’Alessandro, Karis B., additional, De Stefani, Diego, additional, Rizzuto, Rosario, additional, Iino, Masamitsu, additional, Molkentin, Jeffery D., additional, Chandel, Navdeep S., additional, Schumacker, Paul T., additional, and Surmeier, D. James, additional

Published
2022
Full Text
View/download PDF

36. Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort

Author

Shiff, Natalie J., Tupper, Susan, Oen, Kiem, Guzman, Jaime, Lim, Hyun, Lee, Chel Hee, Bryce, Rhonda, Huber, Adam M., Boire, Gilles, Dancey, Paul, Feldman, Brian, Laxer, Ronald, Miettunen, Paivi, Schmeling, Heinrike, Watanabe Duffy, Karen, Levy, Deborah M., Turvey, Stuart, Bolaria, Roxana, Bruns, Alessandra, Cabral, David A., Campillo, Sarah, Chédeville, Gaëlle, Feldman, Debbie Ehrmann, Haddad, Elie, Houghton, Kristin, Johnson, Nicole, Jurencak, Roman, Lang, Bianca, Larche, Maggie, Morishita, Kimberly, Ramsey, Suzanne, Roth, Johannes, Schneider, Rayfel, Scuccimarri, Rosie, Spiegel, Lynn, Stringer, Elizabeth, Tse, Shirley M., Yeung, Rae, Duffy, Ciarán M., and Tucker, Lori B.

Published
2018
Full Text
View/download PDF

38. Validation of the parent global assessment as a health-related quality of life measure in juvenile idiopathic arthritis: results from ReACCh-Out

Author

Oen, Kiem, Toupin-April, Karine, Feldman, Brian M, Berard, Roberta A, Duffy, Ciẚran M, Tucker, Lori B, Tian, Jiahao, Rumsey, Dax G, and Guzman, Jaime

Subjects
Rheumatology, Pharmacology (medical), Clinical Science
Abstract

Objectives To (i) validate the JIA parent global assessment (parent global) as a health-related quality of life (HRQoL) instrument; (ii) evaluate measurement properties of accepted HRQoL measures relative to those of the parent global; and (iii) assess causal pathways determining parent global scores. Methods Data from the Research in Arthritis in Canadian Children emphasizing outcomes (ReACCh-Out) cohort were used. Measurement properties were assessed in 344 patients at enrolment and 6 months later. Causal pathways were tested by structural equation modelling to understand root causes and mediators leading to parent global scores. Results Construct validity was supported by Spearman correlations of 0.53–0.70 for the parent global with the Juvenile Arthritis Quality of Life Questionnaire, Quality of My Life health scale (HRQoML), Pediatric Quality of Life Inventory (PedsQL)-Parent, and Child Health Questionnaire (CHQ)-Physical. Exceptions were PedsQL-Child (0.44) and CHQ-Psychosocial (0.31). Correlations were lower (0.14–0.49) with disease activity measures (physician global assessment of disease activity, active joint count, ESR). Responsiveness of the parent global to improvement according to parent ratings (0.51) was acceptable and within the range (0.32–0.71) of that of other measures. Reliability estimates and measurement errors for all measures were unsatisfactory, likely due to the prolonged time between assessments. Causal pathways for the parent global matched those previously reported for HRQoML. Conclusions Our results offer support for the parent global as a valid measure of HRQoL for JIA. If confirmed, existing studies using the parent global may be re-interpreted, enhancing our knowledge of HRQoL in children with JIA.

Published
2022

43. Comparing Canadian paediatric rheumatology practice to the 2019 ACR Juvenile Idiopathic Arthritis guidelines: results from the CAPRI Registry.

Author

Park, Jonathan, Batthish, Michelle, Berard, Roberta A, Chédeville, Gaëlle, Proulx-Gauthier, Jean-Philippe, Rumsey, Dax G, Tucker, Lori B, Wong, Stephanie, Guzman, Jaime, and Investigators, for the CAPRI Registry

Subjects
BIOTHERAPY, RHEUMATOLOGY, NONSTEROIDAL anti-inflammatory agents, JUVENILE idiopathic arthritis, PEDIATRICS, ACQUISITION of data, MEDICAL protocols, COMPARATIVE studies, SURVEYS, RHEUMATOLOGISTS, METHOTREXATE, ANTIRHEUMATIC agents, MEDICAL records, KAPLAN-Meier estimator, DESCRIPTIVE statistics, RESEARCH funding, SACROILIITIS, LONGITUDINAL method
Abstract

Objective To identify differences between baseline Canadian JIA practices and the 2019 ACR guidelines for JIA. Methods Canadian paediatric rheumatologists were surveyed for their opinions on reasonable a priori target adherence rates for JIA guideline recommendations. Prospectively collected data for 266 newly diagnosed children from 2017 to 2019 were analysed to calculate observed adherence rates. Kaplan–Meier survival curves were used to estimate the cumulative incidence of starting synthetic or biologic DMARDs (sDMARD or bDMARD, respectively) for different patient groups. Results A total of 25/61 (41%) eligible physicians answered the survey. Most survey respondents (64%) felt that adherence targets should vary depending on the strength of the recommendation and quality of evidence, from a mean of 84% for strong recommendations with high-quality evidence to 29% for conditional recommendations with very low-quality evidence. Data showed 13/19 (68%) recommendations would have met proposed targets and 10/19 (53%) had ≥80% observed adherence. Exceptions were the use of subcutaneous vs oral MTX (53%) and infrequent treatment escalation from NSAIDs to bDMARDs in patients with sacroiliitis (31%) or enthesitis (0%). By 12 weeks, 95% of patients with polyarthritis received sDMARDs, 38% of patients with systemic JIA received bDMARDs and 22% of patients with sacroiliitis received bDMARDs. Conclusion Canadian paediatric rheumatology practices were in line with many 2019 JIA guideline recommendations before their publication, except for frequent use of oral MTX and infrequent direct escalation from NSAIDs to bDMARDs in sacroiliitis and enthesitis. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

44. Validation of the parent global assessment as a health-related quality of life measure in juvenile idiopathic arthritis: results from ReACCh-Out.

Author

Oen, Kiem, Toupin-April, Karine, Feldman, Brian M, Berard, Roberta A, Duffy, Ciẚran M, Tucker, Lori B, Tian, Jiahao, Rumsey, Dax G, Guzman, Jaime, and investigators, ReACCh-Out

Subjects
RESEARCH methodology evaluation, RESEARCH methodology, JUVENILE idiopathic arthritis, QUALITY of life
Abstract

Objectives To (i) validate the JIA parent global assessment (parent global) as a health-related quality of life (HRQoL) instrument; (ii) evaluate measurement properties of accepted HRQoL measures relative to those of the parent global; and (iii) assess causal pathways determining parent global scores. Methods Data from the Research in Arthritis in Canadian Children emphasizing outcomes (ReACCh-Out) cohort were used. Measurement properties were assessed in 344 patients at enrolment and 6 months later. Causal pathways were tested by structural equation modelling to understand root causes and mediators leading to parent global scores. Results Construct validity was supported by Spearman correlations of 0.53–0.70 for the parent global with the Juvenile Arthritis Quality of Life Questionnaire, Quality of My Life health scale (HRQoML), Pediatric Quality of Life Inventory (PedsQL)-Parent, and Child Health Questionnaire (CHQ)-Physical. Exceptions were PedsQL-Child (0.44) and CHQ-Psychosocial (0.31). Correlations were lower (0.14–0.49) with disease activity measures (physician global assessment of disease activity, active joint count, ESR). Responsiveness of the parent global to improvement according to parent ratings (0.51) was acceptable and within the range (0.32–0.71) of that of other measures. Reliability estimates and measurement errors for all measures were unsatisfactory, likely due to the prolonged time between assessments. Causal pathways for the parent global matched those previously reported for HRQoML. Conclusions Our results offer support for the parent global as a valid measure of HRQoL for JIA. If confirmed, existing studies using the parent global may be re-interpreted, enhancing our knowledge of HRQoL in children with JIA. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

46. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Author

Onel, Karen B., primary, Horton, Daniel B., additional, Lovell, Daniel J., additional, Shenoi, Susan, additional, Cuello, Carlos A., additional, Angeles‐Han, Sheila T., additional, Becker, Mara L., additional, Cron, Randy Q., additional, Feldman, Brian M., additional, Ferguson, Polly J., additional, Gewanter, Harry, additional, Guzman, Jaime, additional, Kimura, Yukiko, additional, Lee, Tzielan, additional, Murphy, Katherine, additional, Nigrovic, Peter A., additional, Ombrello, Michael J., additional, Rabinovich, C. Egla, additional, Tesher, Melissa, additional, Twilt, Marinka, additional, Klein‐Gitelman, Marisa, additional, Barbar‐Smiley, Fatima, additional, Cooper, Ashley M., additional, Edelheit, Barbara, additional, Gillispie‐Taylor, Miriah, additional, Hays, Kimberly, additional, Mannion, Melissa L., additional, Peterson, Rosemary, additional, Flanagan, Elaine, additional, Saad, Nadine, additional, Sullivan, Nancy, additional, Szymanski, Ann Marie, additional, Trachtman, Rebecca, additional, Turgunbaev, Marat, additional, Veiga, Keila, additional, Turner, Amy S., additional, and Reston, James T., additional

Published
2022
Full Text
View/download PDF

47. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

Author

Onel, Karen B., primary, Horton, Daniel B., additional, Lovell, Daniel J., additional, Shenoi, Susan, additional, Cuello, Carlos A., additional, Angeles‐Han, Sheila T., additional, Becker, Mara L., additional, Cron, Randy Q., additional, Feldman, Brian M., additional, Ferguson, Polly J., additional, Gewanter, Harry, additional, Guzman, Jaime, additional, Kimura, Yukiko, additional, Lee, Tzielan, additional, Murphy, Katherine, additional, Nigrovic, Peter A., additional, Ombrello, Michael J., additional, Rabinovich, C. Egla, additional, Tesher, Melissa, additional, Twilt, Marinka, additional, Klein‐Gitelman, Marisa, additional, Barbar‐Smiley, Fatima, additional, Cooper, Ashley M., additional, Edelheit, Barbara, additional, Gillispie‐Taylor, Miriah, additional, Hays, Kimberly, additional, Mannion, Melissa L., additional, Peterson, Rosemary, additional, Flanagan, Elaine, additional, Saad, Nadine, additional, Sullivan, Nancy, additional, Szymanski, Ann Marie, additional, Trachtman, Rebecca, additional, Turgunbaev, Marat, additional, Veiga, Keila, additional, Turner, Amy S., additional, and Reston, James T., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results